Published on 7/28/2021 in the Prospect News Structured Products Daily.
New Issue: UBS prices $100,000 return optimization securities linked to DocuSign
New York, July 28 – UBS AG, London Branch priced $100,000 of return optimization securities due July 28, 2026 linked to the common stock of DocuSign, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
If DocuSign stock closes at or above the initial price, the payout at maturity will be par plus five times any gain in common stock of DocuSign capped at 94.64%.
Investors will share in any losses.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
| Issuer: | UBS AG, London Branch
|
| Issue: | Return optimization securities
|
| Underlying stock: | DocuSign, Inc. (Nasdaq: DOCU)
|
| Amount: | $100,000
|
| Maturity: | July 28, 2026
|
| Coupon: | 0%
|
| Price: | Par of $10
|
| Payout at maturity: | Par plus five times any gain in common stock of DocuSign, capped at 94.64%; otherwise, exposure to any losses
|
| Initial share price: | $308.50
|
| Pricing date: | July 23
|
| Settlement date: | July 27
|
| Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
| Fees: | 3.5%
|
| Cusip: | 90300L721
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
